342305124 | PUO | 63975551 | | 2307141 | 1/9/2006 12:00:00 AM | s/p ICD implant | | DIS | Admission Date: 2/29/2006 Report Status:
Discharge Date: 3/17/2006
****** FINAL DISCHARGE ORDERS ******
LITTEER , KAMALA 809-34-84-4
Mi Eette E
Service: CAR
DISCHARGE PATIENT ON: 2/12/06 AT 10:00 AM
CONTINGENT UPON HO evaluation
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: SCHOEPPNER , AVA SANFORD , M.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
ACETYLSALICYLIC ACID 325 MG PO QAM
Starting IN AM ( 11/10 )
HOLD IF: resume immediately upon d/c home
Override Notice: Override added on 2/12/06 by OSDOBA , JEANA
on order for TORADOL IV ( ref # 731685144 )
SERIOUS INTERACTION: ASPIRIN &amp; KETOROLAC TROMETHAMINE , INJ
Reason for override: pt currently off plavix
LIPITOR ( ATORVASTATIN ) 80 MG PO DAILY
Override Notice: Override added on 8/19/06 by JESTER , LI
on order for NIASPAN PO ( ref # 219473376 )
POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp;
NIACIN , VIT. B-3 Reason for override:
Home regimen - closely monitored.
COREG ( CARVEDILOL ) 12.5 MG PO BID
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 2
KEFLEX ( CEPHALEXIN ) 250 MG PO QID X 28 doses
Number of Doses Required ( approximate ): 20
PLAVIX ( CLOPIDOGREL ) 75 MG PO DAILY
Starting Saturday ( 9/12 )
Override Notice: Override added on 2/12/06 by OSDOBA , JEANA
on order for TORADOL IV ( ref # 731685144 )
POTENTIALLY SERIOUS INTERACTION: CLOPIDOGREL BISULFATE &amp;
KETOROLAC TROMETHAMINE , INJ Reason for override:
pt currently off plavix
GLIPIZIDE 10 MG PO QAM Starting IN AM ( 3/28 )
LISINOPRIL 40 MG PO QAM Starting IN AM ( 11/10 )
Override Notice: Override added on 8/19/06 by JESTER , LI
on order for ALDACTONE PO ( ref # 589354742 )
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp;
SPIRONOLACTONE Reason for override:
Home medication regimen - closely monitored.
NIASPAN ( NICOTINIC ACID SUSTAINED RELEASE ) 0.5 GM PO BID
Starting IN AM ( 3/28 )
Alert overridden: Override added on 8/19/06 by
JESTER , LI
POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp;
NIACIN , VIT. B-3 Reason for override:
Home regimen - closely monitored.
OXYCODONE 5-10 MG PO Q6H PRN Pain
PAXIL ( PAROXETINE ) 20 MG PO QAM Starting IN AM ( 3/28 )
ALDACTONE ( SPIRONOLACTONE ) 25 MG PO QAM
Starting IN AM ( 3/28 ) Food/Drug Interaction Instruction
Give with meals
Alert overridden: Override added on 8/19/06 by
JESTER , LI
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp;
SPIRONOLACTONE Reason for override:
Home medication regimen - closely monitored.
COUMADIN ( WARFARIN SODIUM ) 4 MG PO x1
Starting Tomorrow ( 11/10 )
Instructions: follow previous coumadin regimen
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Alert overridden: Override added on 2/12/06 by :
POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp;
WARFARIN POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
Reason for override: per previous home regimen
DIET: Patient should measure weight daily
DIET: House / Low chol/low sat. fat
DIET: 2 gram Sodium
ACTIVITY: No heavy lifting/lifting right arm above head x 1 month
Lift restrictions: Do not lift greater then 5-10 pounds
FOLLOW UP APPOINTMENT( S ):
Dr. Ava Schoeppner 7/22/06 9 AM scheduled ,
Arrange INR to be drawn on 2/4/06 with f/u INR's to be drawn every
3-4 days. INR's will be followed by cardilogist
ALLERGY: NKA
ADMIT DIAGNOSIS:
CHF
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
s/p ICD implant
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
CAD ( coronary artery disease ) s/p PPM/AICD ( S/P implanted cardiac
defibrillator ) CHF ( congestive heart failure ) AVR ( cardiac valve
replacement ) CABG ( cardiac bypass graft surgery ) stent ( coronary
stent ) LBBB ( bundle branch block )
OPERATIONS AND PROCEDURES:
none
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
CRT-D placement in EP lab
BRIEF RESUME OF HOSPITAL COURSE:
64 year old man with a history of valvular heart
disease s/p mechanical AVR and CAD/MI s/p CABG and multiple PCIs. EF
15-20% with LBBB morphology on ECG. CRT-D device placed in 10/4
Subsequent pocket infection ( E coli ) prompting removal of the
system. Now admitted for reimplantation of CRT-D device.
S/P procedure today: Guidant Contak Renewal. Leads in RV apex , RAA ,
and CS. DDD 40 - 120. Access via R cephalic and R axillary. No
complications. pCXR
ok. Per attending will defer anticoagulation and plavix.
5/25/06 : pt did well overnight. c/o mild-moderate pain at wound site.
mild swelling , no gross hematoma appreciated. VS , tele , and CXR reviewed.
Plavix will be restarted on saturday. coumadin resumed tomorrow. ASA 325
mg resumed today. f/u w/ dr schoeppner on 2/26/06. have INR checked in 3-4
days.
ADDITIONAL COMMENTS: Please have your INR level checked with Dr. Meduna 3-4 days after
resuming your coumadin. You may resume your plavix on saturday. Please
resume taking a full aspirin ( 325 mg ) tonight when you get home from the
hospital. You may resume your coumadin , at 4 mg per day , tomorrow
( Thursday ).
DISCHARGE CONDITION: Stable
TO DO/PLAN:
No dictated summary
ENTERED BY: OSDOBA , JEANA ( QE84 ) 2/12/06 @ 11:12 AM
****** END OF DISCHARGE ORDERS ******